Enhancing Oncology analysis with Integrated KRAS Assay products and services and RAS Assays
within the swiftly evolving subject of oncology investigate, correct and productive mutation screening is critical for acquiring qualified therapies. The KRAS solutions System plays a pivotal part During this landscape by presenting detailed solutions for KRAS mutation profiling and Evaluation. KRAS mutations, present in approximately 95% of RAS-re